Literature DB >> 28405918

Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8.

Supranee Upanan1, Andrew T McKie2, Gladys O Latunde-Dada2, Sittiruk Roytrakul3, Chairat Uthaipibull3, Peraphan Pothacharoen1, Prachya Kongtawelert1, Suthat Fucharoen4, Somdet Srichairatanakool5.   

Abstract

Atonal homolog 8 (ATOH8) is defined as a positive regulator of hepcidin transcription, which links erythropoietic activity with iron-sensing molecules. In the present study, we investigated the association between hepcidin and ATOH8 expression in β-thalassemia. We found that inhibition of hepcidin expression in β-thalassemia is correlated with reduced ATOH8 expression. Hepatic hepcidin 1 (Hamp1) and Atoh8 mRNA expression were down-regulated in β-thalassemic mice. Hepcidin (HAMP) and ATOH8 mRNA expression were consistently suppressed in Huh7 cells cultured in medium supplemented with β-thalassemia patient serum. The Huh7 cells, which were transfected with ATOH8-FLAG expression plasmid and cultured in the supplemented medium, exhibited increased levels of ATOH8 mRNA, ATOH8-FLAG protein, pSMAD1,5,8, and HAMP mRNA. Interestingly, over-expression of ATOH8 reversed the effects of hepcidin suppression induced by the β-thalassemia patient sera. In conclusion, hepcidin suppression in β-thalassemia is associated with the down-regulation of ATOH8 in response to anemia. We, therefore, suggest that ATOH8 is an important transcriptional regulator of hepcidin in β-thalassemia.

Entities:  

Keywords:  ATOH8; Anemia; Hepcidin; Iron overload; β-Thalassemia

Mesh:

Substances:

Year:  2017        PMID: 28405918     DOI: 10.1007/s12185-017-2231-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  47 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.

Authors:  Duangporn Jamsai; Faten Zaibak; Jim Vadolas; Lucille Voullaire; Kerry J Fowler; Sophie Gazeas; Heidi Peters; Suthat Fucharoen; Robert Williamson; Panayiotis A Ioannou
Journal:  Genomics       Date:  2006-05-02       Impact factor: 5.736

3.  Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression.

Authors:  David M Frazer; Sarah J Wilkins; Deepak Darshan; Alison C Badrick; Gordon D McLaren; Gregory J Anderson
Journal:  Br J Haematol       Date:  2012-03-26       Impact factor: 6.998

4.  A novel mammalian iron-regulated protein involved in intracellular iron metabolism.

Authors:  S Abboud; D J Haile
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

5.  Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.

Authors:  Emilio Ramos; Léon Kautz; Richard Rodriguez; Michael Hansen; Victoria Gabayan; Yelena Ginzburg; Marie-Paule Roth; Elizabeta Nemeth; Tomas Ganz
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

6.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

7.  Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Authors:  Raffaella Origa; Renzo Galanello; Tomas Ganz; Nicolina Giagu; Liliana Maccioni; Gavino Faa; Elizabeta Nemeth
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

8.  Iron loading and its clinical implications.

Authors:  Chaim Hershko
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

9.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.

Authors:  Toshihiko Tanno; Prashanth Porayette; Orapan Sripichai; Seung-Jae Noh; Colleen Byrnes; Ajoy Bhupatiraju; Y Terry Lee; Julia B Goodnough; Omid Harandi; Tomas Ganz; Robert F Paulson; Jeffery L Miller
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

Review 10.  Manipulation of the hepcidin pathway for therapeutic purposes.

Authors:  Eileen Fung; Elizabeta Nemeth
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

View more
  1 in total

Review 1.  Regulation of Iron Homeostasis and Related Diseases.

Authors:  Yikun Li; Xiali Huang; Jingjing Wang; Ruiling Huang; Dan Wan
Journal:  Mediators Inflamm       Date:  2020-05-02       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.